Table 1.
Demographic and metabolic profile of subjects not assuming antihypertensive therapy according to their office and 24 h ABPM BP profile.
| True NT (n = 1721) (group 0) |
WCHT (n = 187) (group 1) |
MH (n = 147) (group 2) |
True HT (n = 907) (group 3) |
ANOVA P value |
Post-hoc Bonferroni (p < 0.05) |
ANCOVA P valuea |
|
|---|---|---|---|---|---|---|---|
| Age (years) | 44.9 ± 14.0 | 58.8 ± 12.5 | 55.3 ± 17.9 | 53.5 ± 14.1 | .0001 | 0 < all | |
| Women (%) | 70.0 | 54.0 | 45.6 | 45.0 | 0 > all | ||
| Diabetes mellitus (%) | 3.5 | 10.2 | 15.6 | 10.0 | 0 < all | ||
| Current smoking (%) | 19.5 | 8.6 | 19.0 | 19.0 | .01 | 1 < all | |
| BMI (Kg/m2) | 24.5 ± 4.1 | 29.1 ± 4.6 | 26.8 ± 4.6 | 26.9 ± 4.3 | .0001 | 1 > 2,3 > 0 | |
| Waist circumference (cm) | 82.9 ± 11.1 | 94.0 ± 11.8 | 89.6 ± 11.1 | 90.3 ± 12.0 | .0001 | 1 > 2,3 > 0 | 0.48 |
| Fasting glucose (mg/dl) | 93.2 ± 18.4 | 101.6 ± 21.8 | 105.0 ± 29.7 | 102.4 ± 26.2 | .0001 | 0 < all | .05 |
| Total cholesterol (mg/dl) | 214.3 ± 38.9 | 230.2 ± 37.5 | 215.4 ± 43.9 | 224.3 ± 39.4 | .0001 | 1,3 > 0 | .001 |
| LDL cholesterol (mg/dl) | 135.5 ± 33.8 | 148.6 ± 30.5 | 136.2 ± 37.2 | 144.0 ± 33.9 | .0001 | 1,3 > 0 | .05 |
| HDL cholesterol (mg/dl) | 58.8 ± 14.4 | 56.9 ± 14.4 | 56.1 ± 16.5 | 55.5 ± 13.3 | .0001 | 3 < 0 | 0.37 |
| Triglycerides (mg/dl) | 100.9 ± 56.1 | 122.6 ± 62.6 | 116.6 ± 67.2 | 126.5 ± 85.6 | .0001 | 0 < all | .001 |
| Serum creatinine (mg/ml) | 0.84 ± 0.16 | 0.90 ± 0.18 | 0.87 ± 0.16 | 0.89 ± 0.18 | .0001 | 1,3 > 0 | 0.17 |
| Uric acid (mg/ml) | 4.1 ± 1.2 | 5.1 ± 1.4 | 4.8 ± 1.2 | 4.9 ± 1.4 | .0001 | 0 < all | 0.22 |
BMI= Body Mass Index.
LDL= Low Density Lipoprotein.
HDL= High Density Lipoprotein.
a
After controlling for age, sex, BMI, smoking, and diabetes mellitus.